Bristol Myers Squibb has released a new Press Release announcing that the European Medicines Agency (EMA) has validated the marketing authorization application for repotrectinib. Repotrectinib […]
+1 700 888 1234
Effingerstrasse 40 3008 Bern Switzerland
Bristol Myers Squibb has released a new Press Release announcing that the European Medicines Agency (EMA) has validated the marketing authorization application for repotrectinib. Repotrectinib […]
Financial impact of lung cancer: A European perspective High risk of financial vulnerability after diagnosis: The majority of people impacted […]
This is an annual initiative led by lung cancer patient organisations, across Europe with the purpose of raising awareness relating […]
Join us at our launch of the 8th LuCE report: “Financial impact on lung cancer: A European Perspective”
November 14th – 15th in Amsterdam We are delighted to announce that Lung Cancer Europe (LuCE) is participating in a two-day meeting […]
We are very sad to share the heartbreaking news that Marjo Forsblom passed away on Sunday October 22nd 2023. Marjo […]